Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
| Reporting guideline provided for? (i.e. exactly what the authors state in the paper) |
Reporting of patent landscapes. |
| Full bibliographic reference | Smith JA, Arshad Z, Trippe A, Collins GS, Brindley DA, Carr AJ. The Reporting Items for Patent Landscapes statement. Nat Biotechnol. 2018;36(11):1043-1047. |
| Language | English |
| PubMed ID | 30412195 |
| Reporting guideline acronym | RIPL |
| Study design | Patent landscapes |
| Applies to the whole report or to individual sections of the report? | Whole report |
| Additional information | Read the background paper by the reporting guideline authors assessing the quality of reporting in patent landscapes in the life sciences: Smith JA, Arshad Z, Thomas H, Carr AJ, Brindley DA. Evidence of insufficient quality of reporting in patent landscapes in the life sciences. Nat Biotechnol. 2017;35(3): 210-214. PMID: 28267720 |
| Record last updated on | November 19, 2021 |